Canaccord Genuity Upgrades Cardiome Pharma (CRME) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

March 28, 2012 11:46 AM EDT
Get Alerts CRME Hot Sheet
Price: $2.33 --0%

Rating Summary:
    8 Buy, 2 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity upgraded shares of Cardiome Pharma (NASDAQ: CRME) from Sell to Hold in a mid-day research note Wednesday. The firm's price target was lowered from $1.50 to $0.85.

The downgrade follows Q4 results from Cardiome late Tuesday.

For an analyst ratings summary and ratings history on Cardiome Pharma click here. For more ratings news on Cardiome Pharma click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Earnings